 | Up a level |
Beelen, Dietrich W., Stelljes, Matthias, Remenyi, Peter, Wagner-Drouet, Eva-Maria, Dreger, Peter, Bethge, Wolfgang, Ciceri, Fabio, Stoelzel, Friedrich, Junghanss, Christian, Labussiere-Wallet, Helene, Schaefer-Eckart, Kerstin, Grigoleit, Goetz U., Scheid, Christof, Patriarca, Francesca, Rambaldi, Alessandro 
ORCID: 0000-0002-3739-7502, Niederwieser, Dietger, Hilgendorf, Inken ORCID: 0000-0003-2038-9730, Russo, Domenico, Socie, Gerard, Holler, Ernst, Glass, Bertram, Casper, Jochen, Wulf, Gerald, Basara, Nadezda, Bieniaszewska, Maria, Stuhler, Gernot, Verbeek, Mareike, La Rocca, Ursula ORCID: 0000-0002-1990-9973, Finke, Juergen, Benedetti, Fabio, Pichlmeier, Uwe, Klein, Anja, Baumgart, Joachim and Markiewicz, Miroslaw ORCID: 0000-0002-8550-8908
(2022).
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.
Am. J. Hematol., 97 (8).
S. 1023 - 1035.
HOBOKEN:
WILEY.
ISSN 1096-8652
Bethge, Wolfgang A., Martus, Peter, Schmitt, Michael, Holtick, Udo, Subklewe, Marion, von Tresckow, Bastian ORCID: 0000-0003-1410-4487, Ayuk, Francis, Wagner-Drouet, Eva Marie, Wulf, Gerald G., Marks, Reinhard, Penack, Olaf, Schnetzke, Ulf, Koenecke, Christian, von Bonin, Malte ORCID: 0000-0002-2995-3230, Stelljes, Matthias, Glass, Bertram, Baldus, Claudia D., Vucinic, Vladan ORCID: 0000-0002-8398-285X, Mougiakakos, Dimitrios, Topp, Max, Fante, Matthias A., Schroers, Roland, Bayir, Lale, Borchmann, Peter, Buecklein, Veit, Hasenkamp, Justin, Hanoun, Christine, Thomas, Simone, Beelen, Dietrich W., Lengerke, Claudia, Kroeger, Nicolaus and Dreger, Peter
(2022).
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany.
Blood, 140 (4).
S. 349 - 359.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020
Dreger, Peter, Holtick, Udo, Subklewe, Marion, von Tresckow, Bastian ORCID: 0000-0003-1410-4487, Ayuk, Francis, Wagner, Eva, Wulf, Gerald, Marks, Reinhardt, Penack, Olaf ORCID: 0000-0003-4876-802X, Schnetzke, Ulf, Koenecke, Christian, von Bonin, Malte, Stelljes, Matthias, Glass, Bertram, Baldus, Claudia D., Vucinic, Vladan ORCID: 0000-0002-8398-285X, Mougiakakos, Dimitrios, Topp, Max, Schroers, Roland, Wolff, Daniel, Thomas, Simone, Kroeger, Nicolaus and Bethge, Wolfgang A.
.
Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience.
Bone Marrow Transplant..
LONDON:
SPRINGERNATURE.
ISSN 1476-5365
Frontzek, Fabian ORCID: 0000-0003-1705-3638, Ziepert, Marita, Nickelsen, Maike, Altmann, Bettina, Glass, Bertram, Haenel, Mathias, Truemper, Lorenz, Held, Gerhard, Bentz, Martin, Borchmann, Peter, Dreyling, Martin, Viardot, Andreas, Kroschinsky, Frank P., Metzner, Bernd, Staiger, Annette M., Horn, Heike, Ott, German, Rosenwald, Andreas, Loeffler, Markus, Lenz, Georg and Schmitz, Norbert
(2021).
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
Lancet Haematol., 8 (4).
S. E267 - 11.
OXFORD:
ELSEVIER SCI LTD.
ISSN 2352-3026
Liebers, Nora, Duell, Johannes, Fitzgerald, Donnacha ORCID: 0000-0003-4927-7484, Kerkhoff, Andrea, Noerenberg, Daniel, Kaebisch, Eva ORCID: 0000-0001-7752-4126, Acker, Fabian ORCID: 0000-0002-6207-0237, Fuhrmann, Stephan ORCID: 0000-0002-7785-2565, Leng, Corinna, Welslau, Manfred, Chemnitz, Jens, Middeke, Jan-Moritz, Weber, Thomas, Holtick, Udo, Trappe, Ralf, Pfannes, Roald, Liersch, Ruediger, Spoer, Christian, Fuxius, Stefan, Gebauer, Niklas, Caille, Leandra, Geer, Thomas, Koenecke, Christian, Keller, Ulrich, Claus, Rainer, Mougiakakos, Dimitrios, Mayer, Stephanie, Huettmann, Andreas, Pott, Christiane, Trummer, Arne, Wulf, Gerald, Brunnberg, Uta, Bullinger, Lars ORCID: 0000-0002-5890-5510, Hess, Georg, Mueller-Tidow, Carsten, Glass, Bertram, Lenz, Georg, Dreger, Peter and Dietrich, Sascha
(2021).
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas.
Blood Adv., 5 (13).
S. 2707 - 2717.
AMSTERDAM:
ELSEVIER.
ISSN 2473-9537